EIM
IGMS

Essex Investment Management’s IGM Biosciences IGMS Stock Holding History

Essex Investment Management’s Portfolio IGMS Stock Details IGMS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-4,073
Closed -$312K – 442
2021
Q1 		$312K Sell
4,073
-105
-3% -$9.56K 0.04% 318
2020
Q4 		$369K Sell
4,178
-19
-0.5% -$1.34K 0.05% 314
2020
Q3 		$310K Sell
4,197
-18
-0.4% -$1.06K 0.04% 330
2020
Q2 		$308K Hold
4,215
– – 0.05% 289
2020
Q1 		$237K Sell
4,215
-785
-16% -$34.4K 0.05% 274
2019
Q4 		$191K Hold
5,000
– – 0.02% 367
2019
Q3 		$89K Buy
+5,000
New +$101K 0.01% 377

Other funds holding IGMS

RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
Alkeon Capital Management
Alkeon Capital Management New York $59.5B AUM 51.63% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
PAMU
Pictet Asset Management (UK) London, United Kingdom $91.8B AUM 47.77% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Essex Investment Management's IGMS Position: Q2 2021 in Review

Essex Investment Management sold out of IGM Biosciences (IGMS) in Q2 2021, closing a stake of 4,073 shares — an estimated $312K sold.

Essex Investment Management first reported a position in IGMS in Q3 2019 and held it in 7 quarters. The position peaked at $369K in Q4 2020. 104 funds tracked by Wall St. Rank hold IGMS as of Q2 2021.

  • Essex Investment Management reported no remaining IGM Biosciences position as of Q2 2021 after selling out during the quarter.
  • Essex Investment Management sold 4,073 IGM Biosciences shares in Q2 2021, an estimated $312K.
  • Essex Investment Management first reported a position in IGM Biosciences in Q3 2019 and held it in 7 quarters.
  • Essex Investment Management's IGM Biosciences position peaked at $369K in Q4 2020.
  • 104 funds tracked by Wall St. Rank held IGM Biosciences as of Q2 2021.

Based on Essex Investment Management's 13F filing for Q2 2021, filed 12 Aug 2021.